A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a ...
CRISPR Therapeutics' recent in vivo CTX310 data validates its technology, marking a fundamental shift and supporting a rating upgrade from Sell to Hold. CASGEVY sales are growing but remain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results